MicroRNAs and deletion of the derivative chromosome 9 in chronic myeloid leukemia

Leukemia

Volumn 23, Issue 1, 2009, Pages 186-188

  Chaubey, A ^b   Karanti, S ^a   Rai, D ^a   Oh, T ^a   Adhvaryu, S G ^b   Aguiar, R C T ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; MICRORNA;

CHROMOSOME 9; CHROMOSOME DELETION; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; DISEASE ASSOCIATION; DOWN REGULATION; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION; GENE TARGETING; GENETIC REGULATION; HEMIZYGOSITY; HUMAN; LETTER; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; RNA PROBE;

EID: 58249098843     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2008.154     Document Type: Letter

References (10)

1. Bartel DP. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-297.
2. Esquela-Kerscher A, Slack FJ. Oncomirs - microRNAs with a role in cancer. Na t Rev Cancer 2006; 6: 259-269.
3. He L, Thomson JM, Hemann MT, Hernando-Monge E, Mu D, Goodson S et al A microRNA polycistron as a potential human oncogene. Nature 2005; 435: 828-833.
4. Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E et al. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 2002; 99: 15524-15529.
5. Fulci V, Chiaretti S, Goldoni M, Azzalin G, Carucci N, Tavolaro S et al. Quantitative technologies establish a novel microRNA profile of chronic lymphocytic leukemia. Blood 2007; 109: 4944-4951.
6. Fourouclas N, Campbell PJ, Bench AJ, Swanton S, Baxter EJ, Huntly BJ et al. Size matters: The prognostic implications of large and small deletions of the derivative 9 chromosome in chronic myeloid leukemia. Haematologica 2006; 91: 952-955.
7. Kreil S, Pfirrmann M, Haferlach C, Waghorn K, Chase A, Hehlmann R et al. Heterogeneous prognostic impact of derivative chromosome 9 deletions in chronic myelogenous leukemia. Blood 2007; 110: 1283-1290.
8. Rai D, Karanti S, Jung I, Dahia PL, Aguiar RC. Coordinated expression of microRNA-155 and predicted target genes in diffuse large B-cell lymphoma. Cancer Genet Cytogenet 2008; 181: 8-15.
9. Reid AG, Tarpey PS, Nacheva EP. High-resolution analysis of acquired genomic imbalances in bone marrow samples from chronic myeloid leukemia patients by use of multiple short DNA probes. Genes Chromosomes Cancer 2003; 37: 282-290.
10. Wilkinson K, Velloso ER, Lopes LF, Lee C, Aster JC, Shipp MA et al Cloning of the t(1;5)(q23;q33) in a myeloproliferative disorder associated with eosinophilia: Involvement of PDGFRB and response to imatinib. Blood 2003; 102: 4187-4190.